GB9805253D0 - Nasal formulation - Google Patents

Nasal formulation

Info

Publication number
GB9805253D0
GB9805253D0 GBGB9805253.3A GB9805253A GB9805253D0 GB 9805253 D0 GB9805253 D0 GB 9805253D0 GB 9805253 A GB9805253 A GB 9805253A GB 9805253 D0 GB9805253 D0 GB 9805253D0
Authority
GB
United Kingdom
Prior art keywords
nasal formulation
nasal
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9805253.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Services Ltd
Original Assignee
Danbiosyst UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst UK Ltd filed Critical Danbiosyst UK Ltd
Priority to GBGB9805253.3A priority Critical patent/GB9805253D0/en
Publication of GB9805253D0 publication Critical patent/GB9805253D0/en
Priority to CA002312839A priority patent/CA2312839C/en
Priority to NZ504786A priority patent/NZ504786A/en
Priority to AU12535/99A priority patent/AU751182B2/en
Priority to PCT/GB1998/003572 priority patent/WO1999027905A1/en
Priority to ES98955814T priority patent/ES2249846T3/en
Priority to JP2000522892A priority patent/JP4754067B2/en
Priority to ARP980106027A priority patent/AR017694A1/en
Priority to EP98955814A priority patent/EP1035833B1/en
Priority to DE69831421T priority patent/DE69831421T2/en
Priority to DK98955814T priority patent/DK1035833T3/en
Priority to AT98955814T priority patent/ATE303131T1/en
Priority to US09/586,139 priority patent/US6342251B1/en
Priority to NO20002851A priority patent/NO329381B1/en
Priority to US09/920,698 priority patent/US20010046519A1/en
Priority to JP2010227620A priority patent/JP2011026341A/en
Ceased legal-status Critical Current

Links

GBGB9805253.3A 1997-12-02 1998-03-13 Nasal formulation Ceased GB9805253D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB9805253.3A GB9805253D0 (en) 1998-03-13 1998-03-13 Nasal formulation
AT98955814T ATE303131T1 (en) 1997-12-02 1998-11-27 COMPOSITIONS FOR NASAL ADMINISTRATION
JP2000522892A JP4754067B2 (en) 1997-12-02 1998-11-27 Composition for nasal administration
EP98955814A EP1035833B1 (en) 1997-12-02 1998-11-27 Compositions for nasal administration
AU12535/99A AU751182B2 (en) 1997-12-02 1998-11-27 Compositions for nasal administration
PCT/GB1998/003572 WO1999027905A1 (en) 1997-12-02 1998-11-27 Compositions for nasal administration
ES98955814T ES2249846T3 (en) 1997-12-02 1998-11-27 COMPOSITIONS FOR NASAL ADMINISTRATION.
CA002312839A CA2312839C (en) 1997-12-02 1998-11-27 Compositions for nasal administration
ARP980106027A AR017694A1 (en) 1997-12-02 1998-11-27 A COMPOSITION FOR THE NASAL ADMINISTRATION OF A PHARMACO TO TREAT ERECTILE DYSFUNCTION, THE USE OF SUCH COMPOSITION IN THE MANUFACTURE OF A MEDICINAL PRODUCT, AND A PROCEDURE FOR THE PREPARATION OF COMPOSITION
NZ504786A NZ504786A (en) 1997-12-02 1998-11-27 Sustained release compositions for nasal administration of drugs for treating erectile disfunction and parkinson's disease
DE69831421T DE69831421T2 (en) 1997-12-02 1998-11-27 COMPOSITIONS FOR NASAL ADMINISTRATION
DK98955814T DK1035833T3 (en) 1997-12-02 1998-11-27 Composition for nasal administration
NO20002851A NO329381B1 (en) 1997-12-02 2000-06-02 Nasal administration compositions for the treatment of erectile dysfunction or Parkinson's disease
US09/586,139 US6342251B1 (en) 1997-12-02 2000-06-02 Compositions for nasal administration
US09/920,698 US20010046519A1 (en) 1997-12-02 2001-08-01 Compositions for nasal administration
JP2010227620A JP2011026341A (en) 1997-12-02 2010-10-07 Composition for nasal administration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9805253.3A GB9805253D0 (en) 1998-03-13 1998-03-13 Nasal formulation

Publications (1)

Publication Number Publication Date
GB9805253D0 true GB9805253D0 (en) 1998-05-06

Family

ID=10828416

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9805253.3A Ceased GB9805253D0 (en) 1997-12-02 1998-03-13 Nasal formulation

Country Status (1)

Country Link
GB (1) GB9805253D0 (en)

Similar Documents

Publication Publication Date Title
GB9726916D0 (en) Nasal formulation
ZA9878B (en) New formulation for inhalation
IL141821A0 (en) Inhaler
HK1041224A1 (en) New pharmaceutical formulation
GB9804013D0 (en) Formulations
ZA9811461B (en) New formulation
HK1026429A1 (en) New formulation
HUP0101096A3 (en) Elektrostatic nasal spray device
GB9813626D0 (en) Nasal antiseptic compositions
HUP0004665A3 (en) Anaesthetic formulation
GB9818927D0 (en) Pharmaceutical formulation
GB9810180D0 (en) Novel formulation
GB9908689D0 (en) Respirator
GB9822333D0 (en) Pharmaceutical formulation
GB9815001D0 (en) Formulations
HUP0105425A3 (en) Suspo-emulsion formulation
GB9828620D0 (en) Medicaments
GB9817470D0 (en) Pharmaceutical formulation
IL126200A0 (en) Nebulizer
GB9805253D0 (en) Nasal formulation
GB9802617D0 (en) Pharmaceutical formulation
GB9725519D0 (en) Nasal formulation
GB9818109D0 (en) Anaesthetic Formulation
GB9823645D0 (en) Formulation
SI1468689T1 (en) 2-methyl-thieno-benzodiazepine formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)